Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals
Diabetologia · 2024
DOI: 10.1007/s00125-024-06116-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetologia, 2024. Verfasst von Rui She und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nephrology, Nordsjællands Hospital, Hillerød, Denmark. Hauptthemen laut MEDLINE: Blood Glucose, Diabetes Mellitus, Type 1, Epinephrine, Glucose Clamp Technique. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, Research Foundation at Nordsjællands Hospital, Copenhagen University.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims/hypothesis As a result of early loss of the glucagon response, adrenaline is the primary counter-regulatory hormone in type 1 diabetes. Diminished adrenaline responses to hypoglycaemia due to counter-regulatory failure are common in type 1 diabetes, and are probably induced by exposure to recurrent hypoglycaemia, however, the metabolic effects of adrenaline have received less research attention, and also there is conflicting evidence regarding adrenaline sensitivity in type 1 diabetes. Thus, we aimed to investigate the metabolic response to adrenaline and explore whether it is modified by prior exposure to hypoglycaemia.
Methods
Eighteen participants with type 1 diabetes and nine healthy participants underwent a three-step ascending adrenaline infusion during a hyperinsulinaemic–euglycaemic clamp. Continuous glucose monitoring data obtained during the week before the study day were used to assess the extent of hypoglycaemia exposure.
Results
While glucose responses during the clamp were similar between people with type 1 diabetes and healthy participants, plasma concentrations of NEFAs and glycerol only increased in the group with type 1 diabetes ( p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Nephrology, Nordsjællands Hospital, Hillerød, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Steno Diabetes Center Copenhagen, Herlev, Denmark.
- Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
- Institute of Pharmaceutical Science, King's College London, London, UK.
- Department of Endocrinology and Nephrology, Nordsjællands Hospital, Hillerød, Denmark. ulrik.pedersen-bjergaard@regionh.dk.
Förderung
- Novo Nordisk Fonden
- Research Foundation at Nordsjællands Hospital
- Copenhagen University
Zitieren
APA
She, R., Suvitaival, T., Andersen, H. U., Hommel, E., Nørgaard, K., Wojtaszewski, J. F. P., Legido-Quigley, C., & Pedersen-Bjergaard, U. (2024). Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals. Diabetologia. https://doi.org/10.1007/s00125-024-06116-5
Vancouver
She R, Suvitaival T, Andersen HU, Hommel E, Nørgaard K, Wojtaszewski JFP, et al. Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals. Diabetologia. 2024. doi:10.1007/s00125-024-06116-5
BibTeX
@article{She2024,
author = {She, Rui and Suvitaival, Tommi and Andersen, Henrik U and Hommel, Eva and Nørgaard, Kirsten and Wojtaszewski, Jørgen F P and Legido-Quigley, Cristina and Pedersen-Bjergaard, Ulrik},
title = {Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals},
journal = {Diabetologia},
year = {2024},
doi = {10.1007/s00125-024-06116-5}
}
EUVIMED